Lv21
190 积分 2026-07-06 加入
HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
5小时前
待确认
Single-cell characterization of anti–LAG-3 and anti–PD-1 combination treatment in patients with melanoma
1个月前
已完结
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
1个月前
已完结
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
1个月前
已完结
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
1个月前
已完结
External Validation of the Phoenix Sepsis Score in Children With Suspected Community-Acquired Sepsis
1个月前
已完结
Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock
1个月前
已完结
Efficacy of PD-1/PD-L1 and LAG-3 immune checkpoint inhibitors in the treatment of patients with solid tumor
1个月前
已完结
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy
1个月前
已完结
Simultaneous Quantification of Multiple Immune Checkpoint Interactions in Melanoma
1个月前
已完结
皖公网安备34019202002308
